Nicotinell Lutschtabletten Mint (Nicotine Bitartrate Dihydrate)

Nicotine, the active ingredient in Nicotinell Lutschtabletten Mint, is a nicotine replacement therapy presented as an oral lozenge for oromucosal use. It helps adult smokers reduce cravings and withdrawal symptoms during smoking cessation attempts. The lozenge is formulated to dissolve slowly, delivering a steady release of nicotine to the oral mucosa.

GNH USA supplies Nicotinell Lutschtabletten Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals, and clinics worldwide, adhering to EU quality standards and providing reliable global distribution.

Nicotine, a nicotine replacement therapy, is used to support smoking cessation by addressing nicotine dependence. - Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms while quitting. - Tobacco dependence: assists individuals who regularly use tobacco to gradually lower nicotine intake. - Relapse prevention: supports people who have quit smoking to maintain abstinence and avoid relapse.

Oral nicotine lozenges may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: feeling of queasiness or upset stomach. - Hiccups: involuntary diaphragm contractions. - Increased salivation: excess saliva production.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Cardiovascular events: chest pain, palpitations, or hypertension. - Severe mouth ulceration: painful lesions that persist or worsen.

Before using Nicotinell Lutschtabletten Mint, consider the following precautions to ensure safe and effective use. - Cardiovascular assessment: patients with recent myocardial infarction or unstable angina should use under medical supervision. - Non‑smoker use: not indicated for individuals who have never smoked nicotine products. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously to prevent overdose. - Alcohol consumption: limit intake as alcohol may increase the likelihood of side effects. - Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Nicotine lozenges can interact with certain medicines; awareness of these interactions helps manage potential risks.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Other nicotine replacement products: combined use can lead to nicotine toxicity. - CYP2A6 inhibitors: may alter nicotine metabolism and increase plasma levels.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may enhance nausea or dizziness. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Alcohol: concurrent use can exacerbate dizziness or hypotension.